Italy

Avas will initially commercialise NaMuscla as a Class C (Tier 2), while Lupin negotiates with AIFA (Agenzia Italiana del Farmaco)…

GlobalData’s latest report reveals that the increase is partly attributed to the increased life expectancy of T1D patients due to…

The aim was to get the companies to meet the vaccine volumes they had promised and not to seek compensation, said Foreign Minister…

Italy has the third highest death toll in the world from COVID-19, with 33,415 people dying since the outbreak came to light on…

Policymakers will have to balance incentives for the pharma sector to scale up production with strict monitoring on environmental…